Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00343096Phase 3Terminated
A Phase 3 trial of lorazepam in status epilepticus (SE), epilepsy. Started Jun 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00343096.